Form 483

Ion Labs Inc. Form 483, 2008-12-31

FDA issued a Form 483 to Ion Labs Inc. on 2008-12-31 with 10 public-safe observations.

483· Form 483 issued10 observations

Ion Labs Inc. · Largo, United States · Issued December 31, 2008

Overview

  • 10 public-safe observations are available for this inspection.
  • 10 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

31 Dec 2008
21 CFR 211.22(a)

Approve or reject components, products

Cited by Daryl A Dewoskin

31 Dec 2008
21 CFR 211.25(b)

Supervisor Training/Education/Experience

Cited by Daryl A Dewoskin

31 Dec 2008
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Daryl A Dewoskin

31 Dec 2008
21 CFR 211.100(b)

SOPs not followed / documented

Cited by Daryl A Dewoskin

31 Dec 2008
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Daryl A Dewoskin

Inspected site

ILIon Labs Inc.Largo, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.182Cited across public-safe Form 483 observations1x
21 CFR 211.188Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x
21 CFR 211.25(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 10 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere